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Abstract
Cocaine is a potent stimulant which affects cardiovascular system severely. The mecha-
nism of cardiac toxicity depends on multiple factors. Cocaine increases sympathetic 
stimulation and causes excess catecholamine secretion. Besides, its indirect sympatho-
mimetic effect also directly exerts cardiotoxic effect by different cellular, molecular, and 
ionic mechanisms, resulting in acute or chronic cardiovascular impairment. Cardiac 
arrhythmia and acute myocardial ischemia or infarction is the most common cause of 
cocaine-induced sudden cardiac death. Chronic cocaine abuse can develop sustained 
hypertension or myocarditis or cardiomyopathy leading to depressed left ventricular 
function. Therapy for cocaine induced cardiac toxicity generally includes use of benzo-
diazepine agents, nitric oxide mediated vasodilators, alpha blockers and even calcium 
channel blockers. Beta blockers are relatively contraindicated in acute settings of cocaine 
cardiovascular toxicity. Hypersensitivity reaction to cocaine is often manifested by infil-
tration of eosinophilic or mononuclear cells without myocardial cell damage. Vascular 
dissection, endocarditis, and tricuspid valvular abnormalities are some less frequent 
manifestations in cocaine-induced cardiac toxicity.
Keywords: cocaine, ischemia, atherosclerosis, cocaine cardiomyopathy, cocaine 
myocarditis
1. Introduction
Cocaine is a potent natural alkaloid derived from the leaves of South American Coca tree 
(Erythroxylum coca). It was known as one of the oldest stimulants that were used by the 
ancient Inca in the Andres Mountain for simultaneous acceleration of their heart and respi-
ratory rate to counter the effect of low pressure of the mountain air in the 3000 B.C. [1]. The 
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drug was first extracted in 1859 by German alchemist Albert Niemen from the coca leaves. 
In the past, cocaine was considered a medicine. Austrian psychoanalyst Sigmund Freud 
used it as a medicine for sexual impotence and depression. However, once hailed as a magi-
cal drug, it is currently known as the most addictive substance on the earth [2].
Cocaine is the second most popular drug addiction after marijuana. According to National 
Survey of Drug Use and Health (NSDUH), cocaine abuse is most common in the young popu-
lation between 18 and 25 years in the United States [3]. The data from 2011 Drug Abuse and 
Warning Network (DAWN) cocaine abuse involve 40% of the total cases of the drug misuse 
cases in the emergency department [4].
Pure cocaine can be abused by chewing coca leaves (Erythroxylum coca). However, the more 
popular way of cocaine abuse is smoking or snorting. On the street, the drug is available in 
hydrochloride salt form or as free base form. In order to prepare hydrochloride salt, pure 
white crystal-like cocaine powder is treated with acid solvent. Hydrochloride salt is most 
commonly snorted or taken through intravenous route as the salt is water soluble. On the 
other hand, free base cocaine is produced by mixing with ammonia and ether as solvent and 
then dried to a powder form. Free base is more pure and more addictive when it is smoked or 
snorted. Crack cocaine is the most commonly used form of free base form of cocaine. Crack 
cocaine is synthesized by heating cocaine hydrochloride and baking soda solution to form a 
hard rock like cocaine base. It crackles when smoked. Drug dealers usually cut cocaine mix-
ing with some adulterants. These additive materials are added to the cocaine to enhance its 
effect as well as increasing the amount. Glucose, mannitol, laundry detergents, laxatives, local 
anesthetic like lignocaine, strychnine, amphetamine are very popular additives while making 
cocaine. “Speed ball” is a popular addictive substance where heroin is added with cocaine [5].
The drug can be absorbed through mucous membranes. The peak effect of cocaine is very fast 
when it is taken by inhalation or intravenous route. However, nasal insufflation of drug exerts 
a slower action as the peak serum concentration is reached after 30–60 minute. Cocaine itself 
inhibits its absorption due to its vasoconstriction effect [5]. Cocaine is rapidly metabolized in 
the body. Its serum half-life is 45–90 minute. Cocaine can be detected for several hours in the 
blood and urine sample after its use. It is metabolized into two major metabolites: benzoylec-
gonine and ecgonine methyl esters, which are capable of producing hypertension. Norcocaine 
is another minor metabolite, also known for its vasoconstrictive effects. Cocaine metabolites 
can be detected in the blood and urine sample even after 4 days of cocaine use. Hair analysis 
is a sensitive marker of detection of cocaine and its metabolites for chronic cocaine abuse [6].
2. Pathogenesis of cocaine cardiac toxicity
Cocaine abuse affects multiple organ systems including the neurological, cardiovascular, 
immune, and hematological systems simultaneously due to its complex pharmacological 
action. It binds to membrane-bound proteins, which include transporters, receptors, and 
voltage-gated ion channels.
• Generalized sympathomimetic activity
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Sympathomimetic effects of cocaine take place when it binds to three monoamine transport-
ers of the nerve terminals: the serotonin transporter (SERT), the dopamine transporter (DAT), 
and the norepinephrine transporter (NET). Cocaine can bind also two neurotransmitter 
receptors: muscarinic and sigma receptors. Interaction with monoamine transporters along 
with neurotransmitter receptors lead to a cascade of cocaine-induced stimulation of central 
sympathetic outflow. Thus, it inhibits reuptake of the neurotransmitters from the extracellular 
space. The increased concentration of the neurotransmitter in the synapse causes enhanced 
postsynaptic transmission. As a result of sympathetic stimulation, cocaine causes vasocon-
striction, hypertension, and increased myocardial oxygen demand [7] (Figure 2).
2.1. Cardiac arrhythmia
Pathophysiology of the cocaine cardiac toxicity further includes inducing cardiac arrhythmia, 
which is one of the very common causes of death in the emergency department. Cocaine-
abuse-related cardiac arrhythmia is considered having multifactorial underlying causes.
• Increase in the concentration of catecholamine and generalized sympathomimetic effect is 
one of the causes of genesis of cardiac arrhythmia triggered by cocaine. Further cocaine-
induced myocardial ischemia or infarction provides a potential substrate for arrhythmia 
[8] (Figure 2).
• Blockade of voltage-gated Na+ and K+ channels
Cocaine is capable of binding to cardiac sodium, potassium calcium channels at clinically 
significant concentration. Inactivation of voltage-gated sodium and potassium channel by 
cocaine leads to intracardiac slowing of conduction and myocardial suppression. In Guinea 
pig model, cocaine blocks ventricular fast voltage-gated Na+ channels in a dose-dependent 
and reversible manner [9, 10]. These result in decreased myocardial contractility, cardiac 
arrhythmia, and decreased left ventricular ejection fraction. Prolongation of the cardiac 
ventricular depolarization period leads to reentrant arrhythmia. Bruguda syndrome like 
electrocardiographic pattern can be secondary to mechanism of cocaine-related Na+ channel 
blockade [11] (Figure 1).
Besides, cocaine on Na+ ion channels also causes blockade of potassium and L-type Ca+ chan-
nels. The potassium current is significantly diminished following the drug abuse. Cocaine 
blocks the human ether–a-go-go-related gene (h-ERG) channel to delay the rectifier K+ cur-
rent (Ikr) and thereby inhibits repolarization phase of the action potential. Prolongation of the action potential results in QT prolongation in habitual cocaine users [12].
At a higher serum concentration, cocaine binds to protein with lower affinity as the proteins 
with high affinity get saturated. At lower concentration, high-affinity monoamine transporters 
are inhibited. It binds to voltage-gated ion channels at a higher concentration as monoamine 
transporters get saturated. In animal model, progressive cocaine poisoning at higher serum 
concentration demonstrates cardiotoxicity along with CNS effect [7].
• Ca+ homeostasis
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Cocaine-induced binding and opening of L-type Ca+ channels causes increase in intracellular 
Ca+ ion concentration due to ionic influx in cardiomyocyte in experimental model. The drug 
promotes opening of L type Ca+2 channels and decreases closing rate. Consequently, intracel-
lular Ca+ level rises and also provides additional reason for cardiac arrhythmia by secondary 
messenger pathway [13].
Calsequestrin is a major Ca2+ storage protein in sarcoplasmic reticulum of the cardiac and skel-
etal muscle cells. Cocaine is capable of disrupting the excitation contraction coupling through 
prevention of polymerization of calseqestrin and its calcium binding capacity in sarcoplasmic 
reticulum of cardiomyocyte. As a result, it reduces sarcoplasmic reticulum Ca2+ storage and 
cytosolic release of Ca2+, leading to cardiac arrhythmia [14] (Figure 1).
2.2. Myocyte damage
Cocaine causes myocardial damage by both direct and indirect pathway resulting in different 
morphological and histological abnormalities including contraction band necrosis, cardiomy-
opathy, myocardial fiber disarray, mononuclear cell infiltration, etc. [11] (Figures 1 and 2).
• Myocardial cell apoptosis
In animal model, cocaine is able to cause apoptosis of the myocardial cells in a dose- and time-
dependent manner through mitochondrial pathway. It is found an increase of cytochrome c 
enzyme levels in the cytosol in comparison with its level in mitochondria in fetal rat myocardial 
cells exposed to different doses of cocaine for different time intervals. Cytosolic cytochrome c binds 
to apoptotic activating factor 1 (Apaaf 1) and d ATP. It produces activated caspase 9, which cleaves 
procaspase 3 to create active caspase 3. Cocaine is believed to cause apoptosis of the myocardial 
cells by increasing caspase protein activities in animal model. Furthermore, cocaine increases Bax 
protein levels and decreases Bcl 2 in vivo to increase caspase activity and mitochondrial cell death 
[11]. Myocardial cell apoptosis is also demonstrated by cocaine-induced rise of p38 MAPK (mito-
gen-activated protein kinase) and inhibition of cytoprotective extracellular signal regulated kinase 
[11]. Wang et al. proposed a role of TNF α in cocaine cardiotoxicity. Myocardial TNF α induces 
myocardial apoptosis through its action causing chronic heart failure in animal model [15].
Figure 1. Schematic diagram of direct effect of cocaine in cardiotoxicity.
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• Mitochondrial dysfunction
Cocaine triggers indirect pathway of myocardial damage by production and accumulation 
of reactive oxidation species (ROS) and reactive nitrogen species (RNS) due to enzymatic or 
nonenzymatic catabolism of the cocaine-induced excess catecholamines, which causes mito-
chondrial damage and cell death.
Cocaine directly inhibits mitochondrial electron transport chain leading to decreased ATP produc-
tion and formation of ROS and RNS. On the other hand, indirect release of high levels of circulatory 
catecholamines disrupts Ca2+ homeostasis. It results in a rise of intramitochondrial Ca2+ overload 
and depletion of ATP production. Moreover, catabolism of catecholamines produces different 
amino chromes (adrenochromes, dopachrome, and noradrenochrome), which are active sources 
of ROS. Further contribution of the mitochondrial ROS production is obtained from the increased 
NADPH oxidase and xanthine oxidase activity on high levels of catecholamines. Increased mito-
chondrial ROS and RNS cause mitochondrial dysfunction and subsequent cardiotoxicity [16].
Figure 2. Schematic diagram of indirect effect of cocaine in cardiotoxicity.
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2.3. Myocardial hypertrophy
It is developed from cocaine-induced sustained hypertension by sympathomimetic effect on 
the heart [17]. In addition, cocaine stimulates α 1 adrenoceptors to increase in total protein 
content along with β myosin heavy chain expression in the myocytes [18, 19]. Cocaine-induced 
production of ROS by stimulating α
1
 adrenoceptors mediated by NADPH oxidase promotes 
hypertrophic growth ventricular myocytes [20, 21]. Finally, cocaine-induced direct activation 
of calcium/calmodulin receptors that culminates in increased phosphorylation of the ryano-
dine receptors leads to increased Ca+ release from sarcoplasmic reticulum and increase in 
protein formation in the myocytes [22] (Figures 1 and 2).
2.4. Effect on the blood vessels
• Atherosclerosis and vasospasm
Cocaine is known for developing premature atherosclerosis even in the young abuser (mean 
age 32 years) [23]. Cocaine and its metabolites induced sympathomimetic effect that leads 
to prolonged vasoconstriction (Figure 2). Endothelial damage secondary to vasoconstric-
tion forms the basis of atherosclerosis. Increase of the histamine and heparin, secreted from 
increased mast cell, is considered to increase endothelial cell permeability [24]. Increased 
endothelial cell permeability secondary to cocaine and coco ethylene (formed following 
cocaine abuse along with alcohol intake) causes deposition of the low-density lipoprotein in 
the vasculature causing atherosclerosis [25].
Cocaine triggers endothelial production of endothelin 1 (ET 1). In animal study, ET 1 is shown 
to have vasoconstriction effect [26, 27]. Endothelium-derived nitric oxide (NO) is a potent 
vasodilator. The bioavailability and biological activity of NO is reduced due to reduced 
expression of endothelial NO synthase (e NOS) in presence of cocaine [28]. Cocaine in clinical 
concentration in abusers can cause significant imbalance between the concentration of the ET 
1 and NO [11] (Figure 1).
• Thrombus formation
Kugelmas reported significant expression of the P-selectin protein on the platelet surface that 
activates alpha granules leading to formation of platelet thrombus. Intravenous administra-
tion of cocaine may cause significant expression of P selectin protein [29]. Hollander et al. in 
their study demonstrated cocaine-induced thromboxane release from activated platelets with 
a decrease in prostacyclin, an inhibitor of platelet aggregation [25].
Production of endogenous thrombosis and thrombolysis may be found through intranasal 
cocaine administration. It is associated with high level of plasminogen activating factor 1 
(PAI 1) [30]. PAI 1 is released with α granules when platelet is activated. It contributes to 
thrombogenic activity by inhibiting fibrinolysis. Altered blood viscosity and increase in Von 
Willebrand factor, a glycoprotein secreted from the endothelial cells, also attribute to cocaine-
mediated thrombogenesis [31].
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Thrombus formation also results from the cocaine-induced increased expression of tissue fac-
tor (TF) and reduced expression of the tissue factor pathway inhibitor (TFPI) in the dysfunc-
tional endothelial cells [32] (Figure 1).
Finally, cocaine inhibits formation of natural anticoagulant antithrombin III and protein C 
contributing to its prothrombotic property [25].
3. Pathology of cocaine cardiac toxicity
The morphological changes in the heart are attributed directly to cocaine toxicity as well as 
to indirect action of the excess catecholamine secretion. Apart from these, the hypothesis on 
myocardial changes can occur due to hypersentivity reaction to cocaine.
3.1. Contraction band necrosis
Excess catecholamine contributes significant changes in the myocardial fibers and that change 
is different from myocardial ischemia and infarction. The change or lesion is known as con-
traction band necrosis (CBN). It is also termed as myofibrillar degeneration and sometimes 
coagulative myocytolysis. CBN can be found in any circumstances related to catecholamine 
excess as well as in drowning, intracerebral hemorrhage, coronary artery occlusion sudden 
cardiac death, and in wide variety of drug overdose like amphetamine, MDMA, phenylpro-
panolamine, etc.
CBN is the earliest visible manifestation of excess catecholamine characterized by presence of 
individual necrotic myocardial cells surrounded by normal healthy myocells unlike ischemia 
where all myocells supplied by a single vessel are damaged. In addition, myofillaments are 
in register in ischemia unlike in CBN where myofillaments are fragmented forming eosin-
ophillic clamps. CBN is a condition where myocytes are hypercontracted with sarcomeres of 
shorter length (less than 1.5 μm). Z lines get thickened and are often termed as “Contraction 
bands.” However, CBN is also considered as ischemic change as it can be developed follow-
ing coronary occlusion and then reperfusion of the ischemic cells. The underlying mechanism 
of formation of CBN is considered diverse; however, intracellular Ca+ overload mediated by 
catecholamine is largely responsible for such morphological alteration [33, 34].
3.2. Myocardial disarray
Cocaine abuse leads to degenerative and inflammatory changes of the myocardium. 
Myocardial disarray is characterized by oblique or perpendicular alignment of the adjacent 
myofibers and joined by short hypertrophied myobridges. It is often associated with CBN, 
interstitial edema, and focal myocardial fibrosis. CBN along with myocardial disarray, fibro-
sis can act as an anatomical substrate to trigger fatal cardiac arrhythmia causing sudden car-
diac death [35].
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3.3. Myocarditis and dilated cardiomyopathy
Virmani et al. in their autopsy study has confirmed cocaine-induced myocarditis is an impor-
tant cause of death in cocaine abuse besides formation of CBN. Different cocaine preparations 
containing different adjuvants, different route of drug delivery, and chronicity of drug abuse 
could be the reason of different histopathological findings [36]. In cocaine-induced myocardi-
tis, small foci of myocytes necrosis are scattered in different areas of the heart associated with 
infiltrations of lymphocytes. Under electron microscope, vacuolization of the sarcoplasmic 
reticulum and loss of myofibrils are found in the lesion. The mononuclear cellular infiltra-
tions can be associated with various degrees of interstitial fibrosis. Biopsy specimen find-
ings that include myocytes necrosis along with mononuclear cellular infiltration containing 
lymphocytes and monocytes secondary reaction to myocytes necrosis may be a result of acute 
cocaine-induced direct cardiotoxicity [37, 38]. Chronic cocaine abuse may lead to develop-
ment of interstitial fibrosis and congestive heart failure [39].
However, mononuclear cell infiltrations as well as eosinophillic infiltration in the myocar-
dium is also postulated as hypersensitivity reaction to cocaine or any contaminants along 
with cocaine. In such cases, the following features are characterized: (1) absence of myocytes 
necrosis, (2) absence of any myocardial hemorrhage, (3) lesions are of same age, and (4) not 
related to dose of the drug. Hypersensitive eosinophillic myocarditis is very often secondary 
to abuse of crack cocaine containing large amount of bicarbonate [33, 37].
Mere cellular infiltration in the myocardium does not indicate development of myocarditis. 
According to Dallas criteria, a lymphocytic infiltration without necrosis does not prove myo-
carditis [33].
Lymphocytic myocarditis serves also anatomic substrate for cardiac arrhythmia and ulti-
mately develops a permanent dilated cardiomyopathy [37].
3.4. Myocardial hypertrophy
Cocaine user’s heart weight found in autopsy studies is usually 10% heavier than mean 
weights predicted by a standard nomogram. ECG study also reaffirms the existence of ven-
tricular hypertrophy in regular cocaine users. Hypertrophied heart includes hypertrophied 
myocytes, increased collagen deposition, perivascular fibrosis, and medial hypertrophy of 
small arterioles [17].
3.5. Myocardial infarction
Cocaine-induced vasospasm or vascular wall thickening causes arteriolar narrowing. In addi-
tion, its positive ionotropic and chronotropic effect leads to myocardial oxygen demand. Rise 
of heart rate and blood pressure after cocaine abuse also contributes to medial thickening of 
the intramyocardial vessels. Finally, atheromatous effect of cocaine contributes to significant 
narrowing of the coronary blood vessels, leading to acute myocardial ischemia and infarction. 
AMI with nonatherosclerotique coronary artery supports the hypothesis of coronary spasm 
and subsequently the thrombus formation with increased myocardial oxygen demand espe-
cially in acute drug intoxication setting [40].
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4. Clinical manifestations of cocaine cardiac toxicity
4.1. Myocardial ischemia and infarction
Myocardial ischemia develops following cocaine abuse due to:
• Increased sympathomimetic effect leading to rise in heart rate and myocardial oxygen 
demand
• Focal vasospasm of the coronary artery
• Increased atherosclerotic changes of the artery.
There is a multifold increased risk of acute MI during initial 1 hour after the use of cocaine use 
even in low-risk patients. Acute MI is manifested in 0.7–6% abusers with cocaine-associated chest 
pain. The incidence is much higher (25%) in younger people aged between 18 and 45 years old 
especially in those who are associated with other cardiac risk factors. Cocaine-associated chest 
pain is often substernal and pressure like associated with atypical presentations like pleuritic chest 
pain, nausea, palpitations, syncope, and vomiting. AMI reported is more among chronic abusers 
than first-time users. Most often, the drug is abused by smoking, intravenous, or intranasal route. 
Both Q and non-Q wave infarcts were found in different studies. About one-third cases of cocaine-
related AMI are associated with normal anatomy of the coronary artery due to focal vasospasm 
of the artery or thrombolysis subsequent to blockade. However, the presence of thrombi or ath-
erosclerosis is also evident in different autopsy studies related to cocaine-related death. Besides, 
myocardial infarction and myocardial ischemia without chest pain are often manifested with ST-T 
wave abnormalities on the ECG. This syndrome is often associated with normal epicardial coro-
nary artery with marked thickening of the walls of the intramural coronary artery. Chronic users 
of cocaine are also susceptible to coronary vasospasm. Prinzmetal’s angina like ST segment eleva-
tion is demonstrated in some abusers during first 2 weeks of withdrawal from cocaine [37, 41, 42].
• Cardiac biomarker
Cocaine-associated myocardial ischemia is not associated with elevation of CK-MB. However, 
elevated CK is demonstrated in 39% of the 49 cocaine users due to rhabdomyolysis, muscular 
trauma, or intramuscular injection. However, troponins are more specific cardiac biomarkers 
for cocaine users followed by CK-MB and CK, which is not specific [41].
Usually, acute ischemia or infarction develops within 12 hour of cocaine abuse. Weber et al. 
proposed a 12-hour observation period for cocaine abusers. High risk patients are identified 
by the following four parameters [43].
• ST segment depression or elevation of 1 mm or more that persisted for more than 1 minute
• elevation of troponin biomarkers
• recurrent chest pain
• hemodynamic instability
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• Therapy consideration
Cocaine-induced ischemia or infarction can be treated with oxygen, aspirin to prevent throm-
bus formation, and nitroglycerine to revert coronary spasm. Nitroglycerine is able to relieve 
the chest pain in approximately half of the cocaine users. Nitroglycerine abolished Ach-
induced vasoconstriction in long-term cocaine users. Intravenous benzodiazepine is used to 
prevent hypertension, tachycardia, academia, and hyperthermia. Benzodiazepine is also used 
to relieve the anxiety and chest pain in cocaine abusers. Phentolamine, an alpha receptor 
blocker, can be used in acute coronary syndrome especially in hypertensive emergencies. In 
a study on 45 patients, phentolamine is able to abolish successfully tachycardia, hypertension 
coronary artery diameter, and coronary sinus blood flow. Phentolamine is also useful for the 
treatment of cocaine-induced chest pain and ST segment elevation. Heparin, clopidogrel, and 
glycoprotein IIb/IIIa inhibitors have been used to lyse thrombus. Calcium channel blockers 
are considered second-line treatment for not responding to benzodiazepines or nitroglycer-
ine. Calcium channel blockers improve heart rate, blood pressure, and myocardial contractil-
ity of the patients. All beta blockers should be avoided in acute setting in cocaine users.
Percutaneous coronary intervention is more desirable in cocaine using patients associated 
with myocardial infarction. Angiography can be important guidance to detect presence of 
thrombus and obstructive disease. Coronary thrombectomy along with glycoprotein IIb/
IIIa inhibitors is advisable during PTCA in cocaine-associated ST segment elevation myocar-
dial infarction. Stent thrombosis is important complication in continued and noncontinued 
cocaine users within approximately 8 months of antiplatelet therapy with bare metal and 
eluting stents [37, 40, 41].
4.2. Cardiac arrhythmia
Fatal cases of ventricular tachycardia, ventricular fibrillation, and sudden death related to cocaine 
abuse are reported frequently. However, cardiac arrhythmia can be manifested with or without 
myocardial ischemia or infarction resulting from the drug abuse. Cocaine prolongs QT interval 
and sometimes develops QT prolongation associated with ventricular tachycardia or Torsade 
de pointes [37]. In hypertrophied myocardium QT interval dispersion (difference between the 
QT length in the lead where it is maximum and QT length in the lead where it is minimum) of 
more than 80 ms, there is a loss of synchronized depolarization developing reentrant arrhythmia 
[17]. Cocaine-related Na+ channel blockade replicates electrocardiographic pattern of Bruguda 
syndrome and is associated with ventricular fibrillation, polymorphic ventricular tachycardia, 
and sudden death in young patients with morphologically normal hearts [6].
• Therapy consideration
There is no specific treatment available for cardiac arrhythmia secondary to cocaine abuse. 
Antiarrhythmic agents class I and III can be avoided as they can further prolong the QT 
interval [44]. Benzodiazepines can be beneficial to manage supraventricular and ventricu-
lar tachycardia and tachyarrhythmia by inhibiting the drug’s central stimulatory effect. In 
addition, it can reduce anxiety and agitation in cocaine abusers. Most atrial arrhythmia can 
also be responded to sedative drugs. The second line of drugs could be calcium channel 
blockers [6].
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Early onset of cardiac arrhythmia following intake of the cocaine can be treated by sodium bicar-
bonate, which can reverse Na+ channel blockade caused by cocaine and normalize the acid base 
balance. Ventricular arrhythmia manifested after several hours of cocaine intake is usually associ-
ated with myocardial ischemia and traditional treatment could be appropriate in such cases [6, 25].
4.3. Congestive heart failure
In long-term and acute cocaine intoxication, cocaine causes systolic dysfunction of the heart 
due to left ventricular dilation, decreased contractility, and increased end-diastolic pressure. 
Dilated cardiomyopathy is a very common complication of chronic cocaine abuse [41]. Left ven-
tricular apical ballooning in Takotsubo cardiomyopathy of the heart is also reported in chronic 
cocaine abuse [44]. In acute cocaine intoxication, myocardial contractility and ejection fraction 
are reduced to increase end diastolic pressure and end systolic blood volume [45]. Chronic 
cocaine abuse leads to left ventricular hypertrophy and prolonged deceleration time [46].
• Therapy consideration
Cocaine-induced heart failure significantly improved following cessation of cocaine intake. 
However, it can be aggravated following resumption of cocaine abuse. Beta blockers are avoided 
in acute setting. In long-term cocaine abuse, cardiac transplantation is not beneficial [41].
5. Miscellaneous clinical manifestations
5.1. Dissection of the blood vessels
Dissection of aorta and coronary arteries is not very common, but it is found in ”Crack” 
cocaine abuser due to severe hypertension and catecholamine release. Aortic medial disease 
and sustained severe hypertension are the usual risk factors. Aortic dissection is initiated by 
transverse tears in the aortic wall. In aortic dissection, tears usually extend through the intima 
and at least halfway through the media. However, in spontaneous coronary dissection, the 
dissection plane lies within media or between media and adventitia. In coronary artery dis-
section, eosinophillic periadventitial inflammation is commonly seen [33].
5.2. Endocarditis and valvular heart disease
Occasionally, in intravenous cocaine abuse, bacterial endocarditis and tricuspid valvular 
heart disease is reported in the literature. The association of the bacterial endocarditis devel-
opment might be due to poor hygiene and frequent drug injection. However, the possibility 
of pathological effect of the cocaine including endothelial damage and thrombus formation 
cannot be ruled out [33, 41].
5.3. Sudden cardiac death
Sudden cardiac death secondary to cocaine abuse is rarely due to AMI. In most cases, cardiac 
arrhythmia is due to complex multifactorial consequence of cocaine cardiac toxicity [47].
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Isolated several single case reports show that acute cocaine fatalities are found very often 
in cocaine body packers and body stuffers [48, 49]. Body packers smuggle by ingesting or 
inserting packets of cocaine or any illicit drugs in several body cavities or orifices to conceal 
them from law enforcement officials as they cross the international borders, and the drugs 
are subsequently retrieved in the country of arrival. Internal concealment of cocaine very 
often poses serious life-threatening conditions among body packers, such as cocaine intoxica-
tion due to rupture of the drug packets. The most serious consequence of such acute drug 
overdose is very often sudden cardiac arrest, cardiac arrhythmia or myocardial ischemia, and 
infarction [50].
Sudden cardiac death is also found in chronic cocaine users where patient’s conditions are 
complicated by poor underlying cardiovascular conditions including coronary artery disease, 
myocarditis, cardiomyopathy, etc. [49].
• Alcohol
Cocaine abusers use alcohol along with drug to enhance the euphoric effect of the drug. 
Simultaneous alcohol use increases the chance of sudden cardiac death by many folds. It is 
found that alcohol increases serum concentration of the drug by 30% if alcohol is consumed 
prior to nasal inhalation of cocaine. However, this effect is not found following intravenous 
administration of cocaine or if it is taken before alcohol consumption. Bioavailability of the 
drug is increased following alcohol-induced nasal vasodilation. In addition, hepatic conver-
sion of the cocaine into cocaethylene in presence of alcohol results in prolonged cardiac toxic-
ity. Coco ethylene is known for increasing heart rate and dysrhythmogenic. The long lasting 
activity of the metabolite is responsible for increased chance of cocaine-induced sudden car-
diac death in presence of alcohol [6, 51].
• Tobacco smoking
Combined tobacco smoking and cocaine abuse is responsible for diminution of the effective 
diameter of the diseased blood vessels. Vascular stenosis most commonly results in acute 
myocardial ischemia or infarction [6].
• HIV infection
In cocaine addicts with HIV infection positive, a cumulative effect of cocaine and HIV infection 
are found in cardiovascular system. It includes increased frequency of coronary wall and adven-
titial infiltration, thickening of the intramyocardial coronary arteries, and myocarditis [52].
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